California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data.
Let's personalize your content